verified SJR 0,432 · Q3 • database Scopus / SJR & Web of Science indexed

France · Elsevier Masson s.r.l.

workspace_premium Q3 — Pharmacology (medical) lock Subscription

Therapie

Therapie is a journal indexed in SJR in Pharmacology (medical) with an H index of 44. It has an SJR impact factor of 0,432 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,432.

ISSN: 0040-5957

Publisher: Elsevier Masson s.r.l.

Category: Pharmacology (medical)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,432 Q3

H-index 44

Acceptance rate pie_chart

34%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,432

H-index

Docs (year)

116

Docs 3y

347

Total refs

4018

Cites 3y

382

Citable 3y

203

Cites/Doc 2y

1.13

Ref/Doc

34.64

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biosimilaires : de la technique au medicoeconomique

What is pharmacoepidemiology? Definition, methods, interest and clinical applications

Depression et neuroplasticite : implication des systemes serotoninergiques

Contribution of Therapeutic Monitoring in the Assessment of Toxic Adverse Effects of Mitotane: a Case Report

Consommation de substances interdites chez le sportif : etude a l'Antenne Medicale de Prevention du Dopage de Midi-Pyrenees (AMPD-MP)

Comment les acteurs moleculaires de la pathologie Alzheimer permettent de comprendre la demence ? Quelles consequences diagnostiques et therapeutiques ?

Comment identifier un signal en addictovigilance ?

Comment evaluer et traiter l'insuffisance cardiaque a fraction d'ejection preservee

Collaboration between academics, small pharmaceutical company and patient organizations in the development of a new formulation of cysteamine in nephropathic cystinosis: A successful story

Colite lymphocytaire probablement due a l'etifoxine : un cas avec rechute apres reintroduction

Chimioprophylaxie de longue duree a la mefloquine : etude des effets indesirables

Bullous Eruption Associated With Dihydropyridines With Cross Reactivity

SHOW MORE ARTICLES

Bleedings Induced by Oral Anticoagulants: a Study of Adverse Drug Reactions Reported to Midi-Pyrenees PharmacoVigilance Centre Between 2003 and 2006

a l'ere de l'automedication, que savent les femmes enceintes des anti-inflammatoires ?

Benefice medical reel estime par comparaisons indirectes

Behavioural Models for the Characterisation of Established and Innovative Antidepressant Agents

Atteinte hepatique secondaire a la prise d'un phytomedicament a base d'isoflavones de soja

Apport des modeles transgeniques dans la recherche de nouvelles cibles pharmacologiques dans l'insuffisance cardiaque : l'exemple du recepteur de l'aldosterone

Antiproliferative Effects of Withanolides from Withania adpressa

Agranulocytose induite par l'ibuprofene ?

Administration intranasale des medicaments a visee systemique : une nouvelle voie pour les opio?Ødes

Administration des medicaments par voie sous-cutanee en soins palliatifs

Acquis et perspectives dans le traitement de l'insuffisance cardiaque

Acouphenes chez un patient traite par bleomycine pour un sarcome de Kaposi

FAQs

Therapie has an SJR of 0,432 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Therapie is 34%.

Therapie

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Therapie?

What is the APC / publication cost?

What is the acceptance rate?